| Financial Year |
March 31 2023 |
| Monetary Funds |
1,658,579,727.40 |
| Held-for-trading Financial Assets |
27,551,913.00 |
| Notes Receivable |
28,677,309.13 |
| Accounts Receivable |
702,155,864.12 |
| Advances to Suppliers |
1,334,347,190.13 |
| Other Receivables |
94,092,962.80 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,856,756,567.82 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
47,362,717.04 |
| Total Current Assets |
6,842,321,640.40 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
719,928,490.48 |
| Investment Properties |
91,222,365.57 |
| Fixed Assetes |
2,334,372,680.86 |
| Under-construction Projects |
170,948,843.68 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
915,681.33 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
483,344,348.88 |
| R&D expenses |
-- |
| Goodwill |
113,064,426.34 |
| Long-Term Deferred and Prepaid Expenses |
26,070,995.38 |
| Deferred Income Tax Assets |
90,978,449.36 |
| Other Non-Current Assets |
998,517,280.10 |
| Sub-Total of Non-Current Assets |
5,419,743,853.47 |
| Total Assets |
12,262,065,493.87 |
| Short-Term Loans |
1,749,469,619.38 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,813,824,594.60 |
| Accounts Payable |
812,690,165.07 |
| Accounts Received In Advance |
2,545,104.74 |
| Employee Compensation Payable |
42,354,685.60 |
| Taxes Payable |
107,431,903.27 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
177,987,196.49 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,704,100.00 |
| Other Current Liabilities |
80,716,478.19 |
| Sub-Total of Current Liabilities |
6,800,475,848.07 |
| Long-term Loans |
651,253,823.36 |
| Bonds Payable |
200,000,000.00 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
18,098,581.49 |
| Deferred Income Tax Liabilities |
42,204,082.44 |
| Other Non-Current Liabilities |
133,769.13 |
| Sub-Total of Non-Current Liabilities |
1,027,477,701.42 |
| Total Liabilities |
7,827,953,549.49 |
| Paid-In Capital(Or Share Stock) |
953,992,980.00 |
| Capital Surplus |
1,479,450,709.06 |
| Surplus Reserve |
179,790,365.56 |
| LESS:Treasury Stock |
160,005,083.52 |
| Undistributed Profits |
1,733,143,521.72 |
| Minority Stockholder's Interest |
232,340,173.13 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,201,771,771.25 |
| Owner's Equity（Stockholder's Equity） |
4,434,111,944.38 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,262,065,493.87 |
